TW356471B - Novel carbocyclic nucleoside agents useful as selective inhibitor of proinflammatory cytokines - Google Patents

Novel carbocyclic nucleoside agents useful as selective inhibitor of proinflammatory cytokines

Info

Publication number: TW356471B
Authority: TW; Taiwan
Prior art keywords: proinflammatory cytokines; agents useful; selective inhibitor; carbocyclic nucleoside; novel carbocyclic
Prior art date: 1993-06-21

Application number

TW083105476A

Other languages

English (en)

Inventor

Iii Carl Keith Edwards

David Roger Borcherding

Original Assignee

Merrell Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-21

Filing date

1994-06-16

Publication date

1999-04-21

1994-06-16 Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc

1999-04-21 Application granted granted Critical

1999-04-21 Publication of TW356471B publication Critical patent/TW356471B/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

TW083105476A 1993-06-21 1994-06-16 Novel carbocyclic nucleoside agents useful as selective inhibitor of proinflammatory cytokines TW356471B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8024993A	1993-06-21	1993-06-21

Publications (1)

Publication Number	Publication Date
TW356471B true TW356471B (en)	1999-04-21

Family

ID=22156170

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW083105476A TW356471B (en)	1993-06-21	1994-06-16	Novel carbocyclic nucleoside agents useful as selective inhibitor of proinflammatory cytokines

Country Status (20)

Country	Link
US (1)	US6541482B2 (zh)
EP (1)	EP0705263B1 (zh)
JP (1)	JP3479077B2 (zh)
KR (1)	KR100337720B1 (zh)
CN (1)	CN1041631C (zh)
AT (1)	ATE151423T1 (zh)
AU (1)	AU677851B2 (zh)
CA (1)	CA2165779C (zh)
DE (1)	DE69402548T2 (zh)
DK (1)	DK0705263T3 (zh)
ES (1)	ES2103131T3 (zh)
FI (1)	FI956142A (zh)
GR (1)	GR3023373T3 (zh)
HU (1)	HUT73412A (zh)
IL (1)	IL110041A0 (zh)
NO (1)	NO312836B1 (zh)
NZ (1)	NZ267322A (zh)
TW (1)	TW356471B (zh)
WO (1)	WO1995000514A1 (zh)
ZA (1)	ZA944256B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0111497D0 (en) *	2001-05-11	2001-07-04	Medical Res Council	Therapeutic methods
GB0114286D0 (en) *	2001-06-12	2001-08-01	Hoffmann La Roche	Nucleoside Derivatives
US20070042978A1 (en) *	2002-12-19	2007-02-22	Jean-Philippe Girard	Nf-hev compositions and methods of use
US7196093B2 (en)	2003-04-09	2007-03-27	General Atomics	Reversible inhibitors of SAH hydrolase and uses thereof
US7517887B2 (en)	2003-04-09	2009-04-14	General Atomics	Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7868011B2 (en)	2003-04-09	2011-01-11	General Atomics	Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US11033821B2 (en)	2003-09-02	2021-06-15	Jeffrey D. Mullen	Systems and methods for location based games and employment of the same on location enabled devices
KR101194622B1 (ko) *	2004-06-02	2012-10-29	다케다 야쿠힌 고교 가부시키가이샤	접합 헤테로시클릭 화합물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN164556B (zh)	1986-03-06	1989-04-08	Takeda Chemical Industries Ltd
US4931559A (en)	1988-01-20	1990-06-05	Regents Of The University Of Minnesota	Optically-active isomers of dideoxycarbocyclic nucleosides
US4916224A (en)	1988-01-20	1990-04-10	Regents Of The University Of Minnesota	Dideoxycarbocyclic nucleosides
GB8815265D0 (en)	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
CA2051012C (en) *	1990-09-14	2002-04-02	David R. Borcherding	Carbocyclic adenosine analogs useful as immunosupressants
AU642526B2 (en)	1990-09-14	1993-10-21	Marion Merrell Dow Inc.	Method of immunosuppression using cyclopentenyl substituted nucleoside analogs and compositions thereof
US5332814A (en) *	1991-11-12	1994-07-26	Ciba-Geigy Corporation	Process for the preparation of carbacyclic nucleosides, and intermediates
AU658698B2 (en)	1991-12-06	1995-04-27	Aventis Pharmaceuticals Inc.	Novel trans cyclopentanyl purine analogs useful as immunosuppressants
GB9204015D0 (en) *	1992-02-25	1992-04-08	Wellcome Found	Therapeutic nucleosides
SK285229B6 (sk) *	1997-05-13	2006-09-07	Lonza Ag	Spôsob výroby derivátov (1R,4S)- alebo (1S,4R)-1-amino-4- (hydroxymetyl)-2-cyklopenténu a enantioméru (1R,4S)-N-butyryl-1- amino-4-(hydroxymetyl)-2-cyklopenténu
JPH11255768A (ja) *	1998-03-09	1999-09-21	Ajinomoto Co Inc	抗ウイルス剤の製造方法

1994
- 1994-05-25 AT AT94918130T patent/ATE151423T1/de not_active IP Right Cessation
- 1994-05-25 ES ES94918130T patent/ES2103131T3/es not_active Expired - Lifetime
- 1994-05-25 WO PCT/US1994/005916 patent/WO1995000514A1/en active IP Right Grant
- 1994-05-25 NZ NZ267322A patent/NZ267322A/en unknown
- 1994-05-25 JP JP50282295A patent/JP3479077B2/ja not_active Expired - Lifetime
- 1994-05-25 KR KR1019950705826A patent/KR100337720B1/ko not_active IP Right Cessation
- 1994-05-25 CA CA002165779A patent/CA2165779C/en not_active Expired - Fee Related
- 1994-05-25 HU HU9503689A patent/HUT73412A/hu unknown
- 1994-05-25 AU AU69583/94A patent/AU677851B2/en not_active Ceased
- 1994-05-25 CN CN94192526A patent/CN1041631C/zh not_active Expired - Fee Related
- 1994-05-25 DK DK94918130.9T patent/DK0705263T3/da active
- 1994-05-25 DE DE69402548T patent/DE69402548T2/de not_active Expired - Lifetime
- 1994-05-25 EP EP94918130A patent/EP0705263B1/en not_active Expired - Lifetime
- 1994-06-15 ZA ZA944256A patent/ZA944256B/xx unknown
- 1994-06-16 TW TW083105476A patent/TW356471B/zh active
- 1994-06-17 IL IL11004194A patent/IL110041A0/xx unknown
1995
- 1995-02-03 US US08/383,339 patent/US6541482B2/en not_active Expired - Fee Related
- 1995-12-20 NO NO19955197A patent/NO312836B1/no unknown
- 1995-12-20 FI FI956142A patent/FI956142A/fi not_active Application Discontinuation
1997
- 1997-05-09 GR GR970401026T patent/GR3023373T3/el unknown

Also Published As

Publication number	Publication date
DE69402548T2 (de)	1997-07-17
NO312836B1 (no)	2002-07-08
AU6958394A (en)	1995-01-17
US20020004508A1 (en)	2002-01-10
IL110041A0 (en)	1994-10-07
JPH08511558A (ja)	1996-12-03
CA2165779A1 (en)	1995-01-05
ES2103131T3 (es)	1997-08-16
WO1995000514A1 (en)	1995-01-05
EP0705263B1 (en)	1997-04-09
ATE151423T1 (de)	1997-04-15
AU677851B2 (en)	1997-05-08
CN1041631C (zh)	1999-01-13
DK0705263T3 (da)	1997-05-05
GR3023373T3 (en)	1997-08-29
HU9503689D0 (en)	1996-02-28
FI956142A0 (fi)	1995-12-20
JP3479077B2 (ja)	2003-12-15
CA2165779C (en)	1998-06-16
KR100337720B1 (ko)	2002-11-02
FI956142A (fi)	1995-12-20
US6541482B2 (en)	2003-04-01
NO955197L (no)	1996-02-16
ZA944256B (en)	1995-02-08
KR960703122A (ko)	1996-06-19
DE69402548D1 (de)	1997-05-15
EP0705263A1 (en)	1996-04-10
NO955197D0 (no)	1995-12-20
HUT73412A (en)	1996-07-29
CN1125946A (zh)	1996-07-03
NZ267322A (en)	1997-09-22

Publication	Publication Date	Title
MXPA04000646A (es)	2004-03-18	Agente antiviral.
TW349843B (en)	1999-01-11	Substituted 1-arylpyrazoles
TR199902923T2 (xx)	2000-11-21	Yumu�ak kas h�cresi �o�almas� inhibit�rleri olarak (imidazol-5-il)metil-2-kuinolinon t�revleri.
DK0892780T3 (da)	2003-03-03	m-Amidinophenylanaloger som faktor Xa-inhibitorer
DE3574014D1 (en)	1989-12-07	Novel biologically active compound having anti-prolyl endopeptidase activity
DE59308619D1 (de)	1998-07-02	Germicide wirkstoffkombinationen
UY26512A1 (es)	2001-07-31	Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
PA8538401A1 (es)	2002-10-28	Pirimidinas inhibidoras de metaloproteinasas de matriz
MY132094A (en)	2007-09-28	Pyrrolo-triazine aniline compounds useful as kinase inhibitors
NO20004531L (no)	2000-10-30	Halogenerte amidinoaminosyre-derivater anvendbare som nitrogenoksid syntase inhibitorer
BR9810459A (pt)	2006-10-03	sais nìtricos dos inibidores de ace
MXPA02006826A (es)	2004-04-05	Un inhibidor de division celular y un metodo de produccion del mismo.
DE60019347D1 (de)	2005-05-12	Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion
IL144686A0 (en)	2002-06-30	Nitroxy derivatives having antinflammatory, analgesic and antithrombotic activity
AP2001002175A0 (en)	2001-06-21	Combination chemotherapy.
ATE215949T1 (de)	2002-04-15	Hydroisochinolinderivate
YU21100A (sh)	2002-11-15	Izohinolini kao urokinazni inhibitori
CA2057786A1 (en)	1992-06-22	Amino and nitro containing tricyclic compounds useful as inhibitors or ace
TW356471B (en)	1999-04-21	Novel carbocyclic nucleoside agents useful as selective inhibitor of proinflammatory cytokines
TR200002580T2 (tr)	2000-11-21	Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
GR3007118T3 (zh)	1993-07-30
CZ92298A3 (cs)	1998-07-15	Inhibitory guanidin proteasy
MXPA02012470A (es)	2004-01-26	Inhibidores de fosfodiesterasa especificos para gmp ciclico.
TW351718B (en)	1999-02-01	Acylated aminoalkanimidazoles and -triazoles
MY132057A (en)	2007-09-28	Quinoxalinones, a process for their preparation and their use